Venture Visionary Partners LLC Eli Lilly & CO Transaction History

Venture Visionary Partners LLC

$2.25 Billion
Q3 2024

A detailed history of Venture Visionary Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Venture Visionary Partners LLC holds 6,506 shares of LLY stock, worth $5.18 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

6,506

Previous 6,531 0.38%

Holding current value

$5.18 Million

Previous $5.91 Million 2.54%

% of portfolio

0.26%

Previous 0.28%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$772.14 - $960.02 $19,303 - $24,000	-25 Reduced 0.38%	6,506 $5.76 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $111,629 - $139,992	154 Added 2.41%	6,531 $5.91 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $60,996 - $81,604	103 Added 1.64%	6,377 $4.96 Million
Q4 2023 Feb 15, 2024	BUY	$525.19 - $619.13 $86,131 - $101,537	164 Added 2.68%	6,274 $3.66 Million
Q4 2023 Jan 24, 2024	SELL	$525.19 - $619.13 $290,430 - $342,378	-553 Reduced 8.3%	6,110 $3.56 Million
Q3 2023 Oct 13, 2023	BUY	$434.7 - $599.3 $102,154 - $140,835	235 Added 3.66%	6,663 $3.58 Million
Q2 2023 Jul 14, 2023	BUY	$350.74 - $468.98 $101,363 - $135,535	289 Added 4.71%	6,428 $3.01 Million
Q1 2023 Apr 13, 2023	SELL	$310.63 - $364.82 $39,450 - $46,332	-127 Reduced 2.03%	6,139 $2.11 Million
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $126,369 - $147,245	-393 Reduced 5.9%	6,266 $2.29 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $99,024 - $112,848	-334 Reduced 4.78%	6,659 $2.15 Million
Q2 2022 Jul 26, 2022	BUY	$278.73 - $327.27 $24,249 - $28,472	87 Added 1.26%	6,993 $2.27 Million
Q1 2022 May 03, 2022	SELL	$234.69 - $291.66 $11,499 - $14,291	-49 Reduced 0.7%	6,906 $1.98 Million
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $12,141 - $15,068	54 Added 0.78%	6,955 $1.91 Million
Q3 2021 Oct 20, 2021	SELL	$221.6 - $272.71 $13,296 - $16,362	-60 Reduced 0.86%	6,901 $1.59 Million
Q2 2021 Aug 05, 2021	SELL	$180.55 - $233.54 $124,218 - $160,675	-688 Reduced 8.99%	6,961 $1.6 Million
Q1 2021 Apr 27, 2021	BUY	$164.32 - $212.72 $356,245 - $461,176	2,168 Added 39.55%	7,649 $1.43 Million
Q4 2020 Jan 27, 2021	BUY	$130.46 - $172.63 $715,051 - $946,185	5,481 New	5,481 $925,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Venture Visionary Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Venture Visionary Partners LLC with notifications on news.

Account

Venture Visionary Partners LLC Eli Lilly & CO Transaction History